...
首页> 外文期刊>ACS Omega >Particulate Systems in the Enhancement of the Antiglaucomatous Drug Pharmacodynamics: A Meta-Analysis Study
【24h】

Particulate Systems in the Enhancement of the Antiglaucomatous Drug Pharmacodynamics: A Meta-Analysis Study

机译:增强抗青光眼药物药效学的颗粒系统:一项荟萃分析研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Glaucoma is a very serious disease that can lead to blindness in severe cases. In an attempt to increase the efficacy of the drugs used in treating this disease, many particulate systems (microano and lipid-basedonlipid-based) have been exploited. In this study, the meta-analysis approach was implemented in order to explore the published studies and extract the literature-based evidence (proof-of-concept studies = 16) that the particulate systems increase the efficiency of the investigated intraocular pressure drugs as demonstrated by the increase in the area under effect curve. Comparison of micron particles versus nanoparticles on the one hand and lipid-based versus nonlipid-based on the other hand, as subgroups of the meta-analysis, was also included in the study where the latter comparison led to insignificant differences, whereas the former has proven the superiority of the nanoparticles over the micronized counterparts.
机译:青光眼是一种非常严重的疾病,在严重的情况下可能导致失明。为了提高用于治疗该疾病的药物的功效,已经开发了许多微粒系统(基于微/纳米和基于脂质/基于非脂质的)。在这项研究中,采用荟萃分析方法以探索已发表的研究并提取基于文献的证据(概念验证研究= 16),该研究表明颗粒系统可提高所研究眼压药物的效率效果曲线下面积的增加。作为荟萃分析的子组,一方面将微米颗粒与纳米颗粒进行比较,另一方面将基于脂质的与基于非脂质的比较也纳入了研究,其中后者的比较导致无显着差异,而前者的比较导致证明了纳米颗粒优于微粉化的对应物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号